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Abstract
Background: Red deer (Cervus elaphus) is regarded as an epidemiologically relevant host for Mycobacterium bovis
(M. bovis) and closely related members of the Mycobacterium tuberculosis complex that cause animal tuberculosis
(TB). The standard antemortem screening test for the detection of TB in deer is the intradermal tuberculin skin test,
but the detection of interferon-gamma (IFNγ) produced by white blood cells exposed to M. bovis antigens can be
used as an alternative or supplemental assay in most TB eradication/control programs. This study aims to develop
an in-house sandwich ELISA for deer IFNγ, based on the cross-reactivity of the antibodies to both cervid and bovine
IFNγ, and to evaluate the potential of this assay to detect M. bovis-infected red deer in response to the in vitro
stimulation of whole-blood cells with bovine purified protein derivative (bPPD), p22 protein complex derived from
bPPD or using the specific tuberculous mycobacterial proteins ESAT-6/CFP-10, Rv3615c and Rv3020c. The positive
control stimulant used in this study was pokeweed mitogen, which resulted in a consistent induction of IFNγ in
samples from red deer, thus allowing the interpretation of the assay.
Results: The percentage of animals correctly classified by this technique as M. bovis non-infected was 100%. The
detection of infected animals as positive was high and ranged widely depending upon the antigen and the cut-off
value applied, as well as the time after infection. Our findings indicate that this protocol may serve as a reliable assay
for the antemortem diagnosis of TB from the initial stage of M. bovis-infection, and may also be adequately sensitive.
Conclusions: The suggested optimal antigens and cut-off are bPPD, p22 and the combination of ESAT-6/CFP-10 and
Rv3020c with a 0.05 Δ optical density, which yielded a up to 100% correct classification of TB positive and negatve red
deer under our experimental conditions. This technique will aid in TB testing of farmed and translocated deer. Future
studies should evaluate the ability of this IFNγ assay to detect specific responses under field conditions.
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Background
Animal tuberculosis (TB) caused by Mycobacterium bovis
(M. bovis) has been identified in a wide range of hosts, in-
cluding both domestic animals and wildlife, which can be-
come reservoirs of infection and contribute to infection
maintenance [1]. This disease has a worldwide distribution
and is still a major infectious disease among the domestic
animals and wildlife in many countries [2–4]. The eradica-
tion of TB in cattle is based on diagnosing infection
through the intradermal tuberculin test and the slaughter
of infected animals or whole herds [5].
The red deer (Cervus elaphus) is considered an epide-
miologically important wildlife host for M. bovis and
closely related members of the M. tuberculosis complex
(MTC) that cause TB [1]. Red deer are also hosts of M.
avium paratuberculosis, which causes paratuberculosis
(PTB) or Johne’s disease. These two diseases, TB and
PTB, are a priority in the management and sanitary con-
trol of farmed deer [6–8]. Deer farming is a growing ac-
tivity in Spain, since the animals produced are used to
restock estates on which they are subsequently hunted
[9]. Pre-movement tests are currently compulsory for
the translocations of live deer in Spain.
Serological tests have been developed and employed to
detect antibodies to M. bovis antigens in deer, but no
assay has to date proven to have an adequate sensitivity
(Se) or specificity (Sp) for routine TB diagnosis in deer
[10–13]. The poor performance of this diagnostic ap-
proach can be attributed to the immunological response
generated in ruminants infected with M. bovis, with a
minor involvement of the humoral response which is
initially counterbalanced by a more effective cell-
mediated immune response (CMI) [14], widely recog-
nized as the main factor involved in the containment of
the infection [15]. TB diagnosis should, therefore, be
based on the evaluation of CMI, which can be deter-
mined using the tuberculin skin test or, alternatively,
interferon-gamma (IFNγ) release assays [16].
The standard antemortem screening test for TB detec-
tion in farmed deer is the intradermal tuberculin skin
test, a diagnostic method designated by the World
Organization for Animal Health [17] which is used
worldwide. This test consists of the inoculation of puri-
fied protein derivative tuberculin (PPD) to measure the
increase in the cervical skin fold thickness induced by a
single inoculation of PPD prepared from M. bovis
(bPPD) (single cervical skin-test, SCST). Another valid
technique is the comparative cervical skin test (CCST),
which consists of also injecting avian PPD, prepared
from M. avium ssp. avium (aPPD) into a separate site in
order to allow a comparative assessment of the skin fold
increase [18, 19].
As an alternative or supplemental assay to the skin
test, in most TB eradication/control programs the CMI
response can also be measured in vitro by an assay that
detects the IFNγ produced by peripheral blood mono-
nuclear cells (PBMCs) exposed to M. bovis antigens
[20, 21]. The IFNγ test has proven to be the best option,
since this cytokine is thought to be involved in immunity
to mycobacterial infections and is released in vitro, and
thus readily measurable by enzyme-linked immunosorb-
ent assays (ELISA) [20–22]. This assay has been accepted
for use as an ancillary test to the intradermal test in the
European Union since 2002 [Council Directive 64/ 432/
EEC, amended by (EC) 1226/2002], as it provides national
TB control programs and industry with an additional tool
for use in curtailing the spread of TB in cattle and other
Bovidae [16, 23]. The European Commission recently
requested the European Food Safety Authority (EFSA) to
issue a scientific opinion on the suitability of the IFNγ test
for its inclusion in Directive 64/432/EEC as an official pri-
mary or stand-alone test and as an equivalent to the intra-
dermal test employed to define the infectious status [24].
When compared to the skin test, the IFNγ avoids the
continuous stimulation of the animal with PPDs, does
not require the animal to be captured twice and prevents
the technical variability associated with assessing skin
test reactions [16, 23, 25]. In cattle, the IFNγ test has an
increased Se with a slightly lower Sp than the intrader-
mal tuberculin test [26, 27]. The Se and Sp of the IFNγ
assay are estimated at 85 to 100% and 70 to 93%, re-
spectively, with the use of bPPDs [23, 25, 27–29]. bPPDs
consist of a complex mixture of proteins and include a
great variety of antigens, many of which are shared with
other mycobacterial species and closely related bacteria,
something that may lead to a lack of Sp [30, 31]. Specific
antigens, which are present in tuberculous mycobacteria
and not in non-tuberculous mycobacteria or M. bovis
Bacillus Calmette-Guérin (BCG), can be used for blood
stimulation in the IFNγ assay in tests that discriminate
between M. avium-exposed and BCG vaccinated individ-
uals [28, 32–35], increasing the Sp of these diagnostic
tests [25, 27–29, 36]. Several antigens have been de-
scribed as potential diagnostic targets (e.g. ESAT-6/CFP-
10, MPB70, MPB83, Rv3615c or Rv3020c) for skin test-
ing, IFNγ assay or antibody response assessment in
domestic livestock and wild animals [27, 36–40].
An assay was designed to detect the IFNγ produced by
red deer leukocytes (Cervigam; Pfizer Animal Health)
that also reacts with the IFNγ produced by reindeer
(Rangifer tarandus), white-tailed deer (Odocoileus
virginianus) and other deer species leukocytes, indicating
that antibodies within the assay are cross-reactive with
the IFNγ produced in these different species [35, 41].
The in vitro measurement of IFNγ production, such as
in the Cervigam assay, served as a useful test for the an-
temortem diagnosis of tuberculosis in Cervidae [41, 42].
However, this product is not currently commercially
Risalde et al. BMC Veterinary Research  (2017) 13:341 Page 2 of 11
available, and it is therefore necessary to develop an al-
ternative protocol suitable for cervids.
Since red deer are, from a taxonomic point of view,
closely related to bovines, many of the tests developed
for bovines used previously in cattle have also been de-
scribed to work in deer. In particular, the high amino
acid sequence homology between Bos taurus and Cervus
elaphus IFNγ (91%, http://www.uniprot.org) made it
likely that antibodies recognising bovine IFNγ would
cross-react wtih cervid IFNγ. This study was designed to
develop an in-house sandwich ELISA for the detection
of cervid IFNγ in red deer, based on the cross-reactivity
of the antibodies specific to bovine IFNγ, and to evaluate
the potential of this assay to detect M. bovis-infected
deer in response to the in vitro stimulation of whole-
blood cells with bPPD, p22 protein complex derived
from bPPD and aPPD or using specific M. bovis pro-
teins, such as ESAT-6/CFP-10, Rv3615c or Rv3020c.
Methods
Animals and experimental design
Fifteen 7–8 month-old female red deer (Cervus elaphus)
calves were obtained from a TB-free red deer farm in
southern Spain (no positive cases and the use of CCST
and bacterial isolation since 2003). All individuals were
tested using ELISA to confirm their MTC antibody-free
status before the study started. The animals were housed
in a class III bio-containment at the NEIKER institute in
Derio (Spain), where the calves were allowed to adapt
for 1 week before starting the study and had ad libitum
food and water.
An experimental infection with M. bovis was carried
out as part of a vaccine trial [43]. For the challenge, a M.
bovis field strain (2008/2575) was propagated in
Middlebrook 7H9 broth containing 10% OADC
Enrichment (Becton, Dickinson and Company, New
Jersey, USA), 0.2% glycerol and 0.05% Tween 80 (v/v).
Bacterial growth was harvested by means of centrifuga-
tion, washed twice and thoroughly re-suspended in
phosphate-buffered saline (PBS) with 0.2% glycerol and
0.05% Tween 80. Bacterial concentration was calculated
by plating serial dilutions on agar-solidified Middlebrook
7H9 and adjusted to 106 colony forming units (CFU)/
ml. The suspension was stored at −80 °C until used.
The animals were sedated with xylazine (Xilagesic 2%;
Laboratorios Calier, Barcelona, Spain) and the inocu-
lum containing 106 CFU of M. bovis in 10 ml of sterile
PBS was administered by intratracheal injection with an
18 G needle.
Blood samples were collected at different time points
during the experiment, including prior to the challenge
(day 0), fifteen days post-inoculation (15 dpi), one
month after challenge (30 dpi) and on the day of the
necropsy (60 dpi).
The animals were sedated with xylazine (Xilagesic 2%)
and euthanized by means of an intravenous injection of
T-61 (Intervet S.A., Salamanca, Spain) at 60 dpi follow-
ing the manufacturer’s instructions. All euthanized
calves were subjected to a systematic necropsy with the
main objective of assessing the presence and extension
of tuberculous lesions. Samples were collected from
head lymphoid tissues, including oropharyngeal tonsil
and mandibular, parotid and retropharyngeal lymph
nodes (LNs), lung, tracheobronchial and mediastinal
LNs, spleen, ileocaecal valve and mesenteric and hepatic
LNs. Liver, kidneys and LNs from other locations were
sampled when suspicious lesions had been observed in
these organs. The samples were placed individually in
sterile bags and stored at −80 °C until the bacteriological
culture took place.
Microbiology
Samples of tissues for the culture of mycobacteria were
thoroughly homogenized in sterile distilled water (2 g in
10 ml or equivalently). Five ml of this suspension were
decontaminated and processed following the manufac-
turer’s instructions in order to inoculate BBL MGIT
tubes supplemented with BBL MGIT PANTA and
BACTEC MGIT growth supplement (Becton, Dickinson
and Company, New Jersey, USA). BBL tubes were incu-
bated for 42 days in a BACTEC MGIT 960 System. The
remaining 5 ml were decontaminated in hexadecyl-
pyridinium chloride at a final concentration of 0.75%
(w/v) for 12–18 h. The samples were centrifuged at
2500 × g for 5 min and the pellets cultured in Coletsos
(bioMèrieux, Madrid, Spain) and Lowenstein-Jensen
with pyruvate (Difco, Becton, Dickinson and Company)
tubes at 37 °C for 4 months. All isolates were spoligo-
typed in order to confirm the strain [44].
Serum antibody detection
Sera obtained by centrifugation (3000 × g for 10 min)
from blood samples at 0, 15, 30 and 60 dpi were tested
in duplicate. We applied an in-house ELISA with some
modifications was described previously by Boadella et al.
[45], using bovine PPD (CZ Veterinaria SL, Lugo, Spain)
as an antigen and protein G horseradish peroxidase
(Sigma-Aldrich Química SA, Madrid, Spain) as a conju-
gate. Sample results were expressed as an ELISA per-
centage (E%) that was calculated using the following
formula: [sample E% = (mean sample optical density
(OD) / 2 × mean of negative control OD) × 100]. The
cut-off values were defined as the ratio of the mean
sample OD to the double of mean OD of the negative
control. Serum samples with E% values greater than 100
were considered positive.
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IFNγ test
Blood samples were collected in tubes with lithium hep-
arin at 0, 15, 30 and 60 dpi and processed at room
temperature within the following 8 h. Blood samples
were dispensed in aliquots into individual wells of a
24-well plate (Becton, Dickinson and Company, New
Jersey, USA) with each antigen/control. Stimulation of
whole blood was performed with aPPD (20 μg/ml),
bPPD (20 μg/ml), a protein complex named p22 (20 μg/
ml), and cocktails of synthetic peptides spanning the full
sequences of early secretory antigenic target-6 kDa and
culture filtrate protein 10 (ESAT-6/CFP-10; 5 μg/ml for
each peptide; AHVLA), Rv3615c (5 μg/ml each peptide)
and Rv3020c (5 μg/ml per peptide). The peptides cock-
tails were kindly provided by Drs G. Jones and M.
Vordermeier (APHA) [46]. Pokeweed mitogen (PWM;
20 μg/ml; Sigma-Aldrich, Spain) was used as a positive
control, while no stimulation (PBS) was employed as a
negative control. The protocol was performed as
described for other species [47, 48]. Blood cultures were
incubated for 24 h at 37 °C in a humidified incubator
(5% CO2). Plasma was harvested after 24 h and stored at
−20 °C until assayed.
The IFNγ levels in non-stimulated and stimulated
plasma were determined using an in-house sandwich
ELISA that specifically detects this soluble cytokine
using commercially available monoclonal antibody
(mAbs) pairs for bovine IFNγ (Serotec, Oxford, UK).
Microplates (Nunc Maxisorb, Roskilde, Denmark) were
coated with 50 μl of highly purified anti-IFNγ Abs at
5 μg/ml in PBS (pH 7.5) and incubated at 4 °C overnight.
After a blocking step with 75 μl of PBS, 0.05% Tween-20
and 2% bovine serum albumin for 1 h at room
temperature, the plates were washed 3 times with PBS/
Tween-20 and incubated with 50 μl of plasma diluted
1:2 for 1 h at 37 °C. The plates were then washed 3
times and incubated with 50 μl of biotinylated anti-IFNγ
Abs at 5 μg/ml for 1 h at room temperature. This was
followed by another washing step and the addition of
50 μl of streptavidin–peroxidase (1,2000; Southern
Biotech, Birmingham, USA) for 45 min at room
temperature. After a final wash, 100 μl of chromogenic
substrate (Fast OPD, Sigma-Aldrich, Spain) were added
and the reaction was stopped with 50 μl of 3 N H2SO4.
The OD was measured in a spectrophotometer at
450 nm. Optimal concentrations of mAbs were deter-
mined by evaluating the responses to 1, 2, 5, 10 and
20 μg/ml of each Ab. Individual samples were analyzed
in duplicate and the assay was repeated if the duplicate
responses were not consistent. The data were presented
as OD readings or as differences between the response
to antigen or mitogen and the response to PBS (Δ OD).
Results for a given sample were only validated when
PWM Δ OD was higher than or equal to 0.5 and low
OD readouts were obtained in non-stimulated wells
(PBS wells).
IFNγ test was performed by an experienced researcher
but with no previous knowledge of which sample was
being analyzed. The interpretation of the responses was
based on methods commonly used in the Spanish
National Bovine Tuberculosis Eradication Program for
Bovigam assay and in the former commercial Cervigam
assay. The responses to the bPPD and p22 must exceed
the responses to both aPPD and PBS by a given cut-off
(0.1 or 0.05 Δ OD) to be considered positive. The re-
sponses to the specific antigens (ESAT-6/CFP-10,
Rv3615c and Rv3020c) were compared with the re-
sponses to PBS.
M. bovis proteins selection
bPPD consists of a complex mixture of proteins from M.
bovis and includes a great variety of antigens, being the
most common antigen used for in vitro IFNγ assays
[27]. Recently, a new immunopurified subcomplex pro-
tein named as P22 was purified by affinity chromatog-
raphy from bPPD (CZ Veterinaria SL, Porriño, Spain),
and could become a solid alternative to bPPD for detect-
ing antibodies against MTC. P22 is composed of several
antigens including MPB83, ESAT-6, CFP-10 and, espe-
cially MPB70. It improves standardization and reprodu-
cibility by different laboratories (patent EP16382579).
ESAT-6 and CFP-10 are two of the major antigenic tar-
gets identified in both cattle and human MTC [49, 50].
These proteins are absent in BCG vaccine strains [51]
and can therefore serve as targets for differentiating
vaccinated from infected animals (DIVA test) [52]. The
cocktail ESAT-6/CFP-10 supports the notion that a
combination of epitopes of different antigens increases
the diagnostic Se without compromising Sp [36, 53].
The antigen Rv3615c can also be used in combination
with ESAT-6/CFP-10 (PC-HP, Prionics, Schlieren,
Switzerland) or alone, detecting a significant portion of
TB infected animals that were negative to the ESAT-6/
CFP-10 peptides cocktail [54] or recognizing a signifi-
cant proportion (37%) of infected animals but not in
BCG vaccinates [39]. Moreover, Jones et al. demon-
strated that the antigen Rv3020c also induced IFNγ
production in whole blood from M. bovis-infected ani-
mals but not from BCG-vaccinated cattle [45]. Both
candidate antigens have been tested for their DIVA
capabilities and showed promising results when used as
antigens in the BOVIGAM® assay as well as for skin
testing [55–57].
Statistical analyses
ELISA data were analyzed by means of a one-way variance
analysis followed by a Tukey-Kramer multiple comparison
test. This approach was followed to test for statistical
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differences in ELISA values through time. The t-test was
employed to search for statistical differences in IFNγ levels
(OD) in the different times post-inoculation with regard
to 0 dpi for any of the mycobacterial antigens, mitogen
and negative control used to stimulate IFNγ production.
Pearson’s product-moment correlations were computed
between the IFNγ levels in plasma stimulated with differ-
ent antigens. Concordance between the IFNγ test and
antibody levels to bPPD measured using ELISA was calcu-
lated by means of Cohen’s κ coefficient. Statistical analyses
were run on GraphPad Prism 5 software (GraphPad Soft-
ware, Inc., La Jolla, CA, USA).
Results
The animals were observed daily throughout the experi-
ment and clinical signs of TB were detected, including
those of depression, cough, dyspnoea and open-mouth
breathing. The intratracheal inoculation of M. bovis in
the deer resulted in gross tuberculosis lesions in every
animal, which were especially prominent in lung, tra-
cheobronchial and mediastinal LNs. A bacteriological
culture confirmed M. bovis infection in all the animals
and spoligotyping confirmed the only presence of the
administered M. bovis strain.
ELISA responses to bPPD of infected deer were low
before and immediately after (15dpi) infection but in-
creased thereafter progresively up to 60 dpi (p < 0.05),
when 70% of the infected animals were tested as positive
to the disease with this technique (mean of 121%, with a
cut-off equal to or greater than 100%) (Fig. 1 and
Additional file 1. Table S1).
The stimulation of whole-blood cultures with PWM
after 24 h of incubation at 37 °C led to responses of
IFNγ in plasma that exceeded an OD of 0.5 at every time
point tested. The production of IFNγ increased signifi-
cantly during the course of the study (0.5 at the time of
inoculation when compared to 0.88 at 30 dpi; p < 0.05)
(Fig. 2), but some of the animals became less responsive
to PWM (PWM OD< 0.5) at 60 dpi. However, controls
(PBS) were consistently low throughout the experiment
(OD, 0.20 ± 0.018), and we found no alterations after in-
fecting the deer withM. bovis (Fig. 2 and Additional file 2.
Table S2).
As early as 15 dpi, and at most time points thereafter
until the completion of the study (60 dpi), the IFNγ
responses of the infected deer to bPPD and p22 signifi-
cantly exceeded those prior to the challenge (p < 0.05),
peaking at 30 dpi (0.88 for bPPD and 0.67 for p22;
p < 0.001). Several specific antigens produced by
pathogenic mycobacteria of the M. tuberculosis com-
plex but not by environmental or non-M. tuberculosis
complex pathogens were evaluated as an approach to
decrease the detection likelihood of false positive ani-
mals. We observed that whole blood samples stimu-
lated with ESAT-6/CFP-10 and Rv3020c significantly
increased the levels of IFNγ after M. bovis challenge
during the course of the experiment (p < 0.05). This
was not the case for Rv3615c, which induced signficantly
elevated responses only at 15 dpi (p < 0.05;Fig. 2). The
ESAT-6/CFP-10 and Rv3020c responses followed kinetics
similar to those shown by PPDs and PWM, peaking at 30
dpi and dropping slightly at 60 dpi. The responses of IFNγ
to aPPD differed at 30 and 60 dpi, but only increased by
0.2 in OD when compared with the pre-infection levels
(Fig. 2).
The mean IFNγ responses (averaged over various time
points) of infected deer to different mycobacterial antigens
with regard to PBS in whole-blood were also evaluated. At
the time of infection, the OD values for mycobacterial
antigen stimulation were very low and similar to those of
PBS. There were no significant differences at this time,
with the exception of IFNγ levels in response to PWM
(p < 0.05). The responses in samples stimulated with
aPPD, Rv3615c and Rv3020c remained low during the
course of the study and were not statistically different
from PBS (p < 0.05) after infection, with the exception of
an increase to Rv3020c at 30 dpi. However, the IFNγ re-
sponses of infected deer were higher at all time points
after stimulation with either PWM, bPPD, p22 and ESAT-
6/CFP-10 as compared to those with PBS, and there were
statistically significant changes in all the antigens tested
(p < 0.001). The mean IFNγ responses decreased only
slightly at 60 days after M. bovis infection.
The interpretation of the responses to different anti-
gens was based on protocols commonly used for the
Fig. 1 Individual red deer antibody levels (in ELISA percentage, E%)
to bovine purified protein derivative (bPPD) measured by using ELISA
immediately before and until 60 days post-inoculation of M. bovis.
Serum samples with E% values greater than 100 were considered
positive (horizontal grey line). *Significant differences (p < 0.05)
between pre-inoculation values and those from different post-
inoculation time points
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Bovigam assay in cattle or other farmed bovines. The re-
sponses to bPPD and p22 must be higher to both aPPD
and PBS responses by 0.1 or 0.05 ΔOD to be considered
positive. The responses to the specific antigens (ESAT-6/
CFP-10, Rv3615c and Rv3020c) were compared to PBS
(OD > 0.05 or 0.1). In order to evaluate the nonspecific
responses to M. bovis antigens in non-infected deer,
samples were collected from the TB-free deer before M.
bovis inoculation (n = 15) and the production of IFNγ in
response to mycobacterial antigens and mitogen was
measured. All deer had responses to PWM (OD > 0.5);
however, none of them had a response to mycobacter-
ial antigens, independently of the cut-off value (data
not shown).
Only results in which the control mitogen responses
exceeded OD values of 0.5 were used for the evaluation
of the test. Only 10 animals had PWM responses that
exceeded 0.5 ΔOD at 60 dpi. Table 1 shows the differ-
ences in the percentage of positive samples to the IFNγ
assay regarding M. bovis-infected deer depending on the
time post-infection, the antigen used or the cut-off
value. The differences in test Se were therefore detected
at different times of infection for every mycobacterial
antigen analyzed with both cut-off points. We observed
a higher proportion of positive samples at 30 dpi, which
decreased considerably at necropsy time (60 dpi), when
the number of animals with a response to the mitogen
also declined. In the earlier stages of infection, a higher
Fig. 2 IFNγ responses in plasma from heparinized blood stimulated in M. bovis-infected red deer (n = 15) presented as mean (±SD) of the optical
density at 450 nm (OD450nm) to Pokeweed mitogen (PWM), negative control (phosphate-buffered saline, PBS), bovine and avian purified protein
derivatives (PPD), p22; early secretory antigenic target-6 kDa and culture filtrate protein 10 (ESAT-6/CFP-10), Rv3615c and Rv3020c. *Statistically
significant differences (p < 0.05) observed at specific time points since M. bovis infection in comparison to pre-inoculation values
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proportion of positive samples was obtained with bPPD,
p22 and ESAT-6/CFP-10 (85% to 92.8% Se at 15 dpi and
85% to 100% Se at 30 dpi) when compared to Rv3615c
and Rv3020c (40% to 66.6% Se at 15 dpi and 26.6% to
100% Se at 30 dpi). The specific antigens ESAT-6/CFP-
10, Rv3615c and Rv3020c are usually applied in parallel,
and a test is thus positive if an animal responds to one
of these cocktails. The evaluation in parallel of ESAT-6/
CFP-10 with Rv3615c and Rv3020c considerably in-
creased the Se of the technique when compared to the
separate use of these antigens. At a cut-off value of 0.1
there were more differences between antigens but the
detection of animals infected with M. bovis by the test
was lower, whereas smaller differences and a higher per-
centage of infected animals were found when using 0.05
as the cut-off for the assay (Table 1).
IFNγ responses to PWM, bPPD, aPPD, p22 and ESAT-
6/CFP-10 were strongly correlated in M. bovis-infected
deer (p < 0.001). The correlations between the responses
to Rv3615c, Rv3020c and the other mycobacterial anti-
gens were moderately positive (p < 0.05) (Additional file 3.
Table S3).
The agreement (kappa value) reported between the
IFN-γ assays and the antibody levels to bPPD measured
using ELISA depended on the time post-infection, the
antigen used and the cut-off value applied
(Additional file 4. Table S4). The agreement between
these techniques was 0 at the early stage of the disease,
regardless of the cut-off value applied. Thereafter, the
agreement between both techniques increased for all
the antigens when micobacterial antibodies were pro-
duced, except in the case of Rv3615c. At necropsy time,
the agreement obtained between the IFN-γ assay and
ELISA for bPPD antibodies analyzed with the cut-off
detailed in Spanish guidelines (0.05) varied from good
to very good (0.73 < k < 0.86) in the case of all the anti-
gens used, with the exception of Rv3615c, and good
values of proportion of positive samples were main-
tained with this IFN-γ test (Table 1).
Discussion
The main goal of this study was to assess the ability of an
in-house sandwich ELISA to detect the IFNγ produced by
M. bovis-infected deer in response to in vitro stimulation
with bPPD, p22 and aPPD or using specific M. bovis pro-
teins, such as ESAT-6/CFP-10, Rv3615c or Rv3020c.
The development of IFNγ assays is an important ad-
vance in the diagnosis of TB infection as regards meas-
uring an effective CMI response. The results of our
study also demonstrate that the in-house sandwich
ELISA based on the cross-reactivity with bovine IFNγ
detects the IFNγ response produced by stimulated
leukocytes from experimentally M. bovis-infected red
deer. The optimization of an in-house sandwich ELISA
has many advantages because it is relatively inexpensive
and can be easily automated to process large numbers of
samples. Moreover, the ability to modify IFNγ test
parameters provides challenges to ensure the
standardization of testing procedures and quality assur-
ance, making it possible to provide a closer adaptation
of this assay to the needs of different species of wild ru-
minants within a TB program.
The initial development of IFNγ-based tests for TB sur-
veillance requires a powerful stimulation with mitogens or
superantigens to effectively demonstrate the functional
capacity of the sample or to detect an underlying CMI
response suppression, thereby reducing the risk of false-
negative test results. Prior studies have identified the
PWM as a reliable trigger of the IFNγ production in other
cervids [11, 41, 42, 58]. PWM was also the mitogen used
as the positive control stimulant in this study and resulted
in a consistent induction of acceptable quantities of IFNγ
in samples from red deer, thus favoring the interpretation
of the assay. Although PWM elicited a consistent positive
control stimulus for the leukocytes with an OD greater
than or equal to 0.5, the highest OD observed was 0.88,
while in other experiences with reindeer the OD of the
IFNγ response fluctuated from 1 to 1.8 when using the
Cervigam test [41, 42, 58]. However, Waters et al. (2008)
Table 1 Percentage (%) of positive samples to IFNγ assay (95% Wilson’s confidence intervals) from M. bovis-infected deer
15 dpi 30 dpi 60 dpi
< 0.1 (%) < 0.05 (%) < 0.1 (%) < 0.05 (%) < 0.1 (%) < 0.05 (%)
bPPD 92.8 (68.5–98.7) 92.8 (68.5–98.7) 100 (79.6–100) 100 (79.6–100) 75 (40.9–92.9) 75 (40.9–92.9)
P22 85.7 (60.1–96) 92.8 (68.5–98.7) 100 (79.6–100) 100 (79.6–100) 75 (40.9–92.9) 87.5 (52.9–97.8)
ESAT-6/CFP-10 92.3 (66.7–98.6) 92.3 (66.7–98.6) 85.7 (60.1–96) 100 (79.6–100) 75 (40.9–92.9) 75 (40.9–92.9)
Rv3615c 40 (19.8–64.3) 40 (19.8–64.3) 26.6 (10.9–52) 26.6 (10.9–52) 25 (7.1–59.1) 37.5 (13.7–69.4)
Rv3020c 53.3 (41.7–84.8) 66.6 (30.1–75.2) 73.3 (48–89.1) 100 (79.6–100) 75 (40.9–92.9) 87.5 (52.9–97.8)
ESAT-6/CFP-10 + Rv3615c 92.3 (66.7–98.6) 92.3 (66.7–98.6) 86.6 (62.1–96.3) 100 (79.6–100) 75 (40.9–92.9) 87.5 (52.9–97.8)
ESAT-6/CFP-10 + Rv3020c 93.3 (70.2–98.8) 93.3 (70.2–98.8) 100 (79.6–100) 100 (79.6–100) 75 (40.9–92.9) 87.5 (52.9–97.8)
IFNγ interferon gamma, bPPD bovine purified protein derivative, ESAT-6/CFP-10 early secretory antigenic target-6 kDa and culture filtrate protein 10; dpi:
days post-infection
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found a low OD response to the mitogen and evidenced
of a limited usefulness of the Cervigam in samples from
white-tailed deer, elk (Cervus canadensis) and fallow deer
(Dama dama) [58].
The red deer used in this study were obtained from a
TB-free farm and were negative to antibodies against
bPPD when using ELISA before the experiment started.
The animals were intratracheally challenged with M.
bovis and infection was confirmed by means of path-
ology and culture. It is worth noting that some red deer
responded with antibodies to bPPD from 30 dpi onwards
and that, according to the ELISA test, most of them
were positive to M. bovis at necropsy time (60 dpi). The
antibody response was not directly correlated with the
IFNγ results until 60 dpi (k = 0.73 with 95% confidence
intervals), given that the development of humoral
immunity to M. bovis takes longer than that of cell-
mediated immunity, even in deer where the humoral
immune response is initiated earlier than in other
animals [6].
In effective TB eradication programs, the early detec-
tion of infected animals is a key to avoid maintaining
and disseminating the infection. Significant efforts have
therefore been made to improve the Se of diagnostic
methods using ancillary tests such as the IFNγ assay.
This test is expected to identify infected individuals at
an earlier stage of infection than the skin test and the
antibody ELISA [16, 59–62]. In this study, IFNγ produc-
tion was found as early as 15 dpi, thus enabling us to
diagnose the disease at the initial stage, prior to the de-
tection of serum antibodies.
Both nonspecific responses to PWM and specific re-
sponses to mycobacterial antigens varied widely between
individual deer over time. This led us to exclude some
samples at necropsy time owing to their inability to pro-
duce IFNγ in response to PWM (OD less than 0.5). This
poor response to mitogen stimulation indicated a
concurrent poor response to mycobacterial antigens,
suggesting that either the assay was unable to detect the
cytokine consistently or the leukocytes from M. bovis-in-
fected deer were unable to produce IFNγ after 60 dpi.
The inconsistent detection of IFNγ in the assay may be
discarded because we detected a good response of this
cytokine throughout the study with the protocol devel-
oped; the alterations in the immune response that affect
the kinetics of the cytokine response would, therefore,
be the most probably associated factor. Some immuno-
logical factors that depress the cell-mediated immunuty
decrease the probability of detecting infected cattle in a
context of impaired CMI response to mycobacterial an-
tigens in IFNγ and skin tests, thus affecting their Se
[58, 63, 64]. This state of “anergy” is recorded in animals
subjected to stress and in cattle with advanced or general-
ized TB [10, 65]. This agrees with the findings observed in
our study, in which the deer inoculated intratracheally
with 106 CFU of M. bovis had generalized TB with a
massive growth of mycobacteria in different tissues [43],
which could explain this state of immunosuppression at
60 dpi. However, the suppression of the CMI appears to
drift to a humoral immune response according to the re-
sponse of antibodies to bPPD observed at necropsy time.
This suggests that a combination of CMI-based tech-
niques and the ELISA as an ancillary test for the detection
of antibodies may increase the detection of infected ani-
mals, thus helping to control TB [66].
bPPD and aPPD, along with antigens specific for M.
bovis, have been evaluated in this study for the diagno-
sis of TB in red deer using the IFNγ test. Responses to
bPPD and p22 greater than 0.1 or 0.05 ΔOD with re-
gard to aPPD and PBS are generally considered positive,
while the responses to ESAT-6/CFP-10, Rv3615c and
Rv3020c were compared only with PBS. However, cut-
off levels similar to those for tuberculin are being ap-
plied in cattle when considering these antigens (antigen
minus PBS > 0.05 or 0.1) [45]. In the current study, we
used samples obtained before the challenge and no deer
had an IFNγ response to any of the antigens tested, as
in previous studies of ruminants [25, 28, 29, 67]. After
infection, the highest percentage of detection of infected
deer with the IFNγ assay was for bPPD at the initial stage
of the disease (92.8 to 100%) in comparison with other an-
tigens, which is again in parallel with previous reports for
ruminants [23, 25, 28, 29, 36, 41]. These results were the
same as those obtained with the p22 stimulation when the
0.05 threshold was used (r = 0.9; p < 0.0001). However,
slight differences in the identification of tuberculous ani-
mals were detected in the positive samples when using dif-
ferent antigens and the 0.1 cut-off point, indicating a
lower degree of variation with a more stringent cut-off.
In this study, TB gave rise to a very slight cross-
reactivity with aPPD, since OD values of aPPD were
considerably lower than the readings produced when
using bPPD. In field conditions, the exposure to M.
avium or environmental non-tuberculous Mycobacter-
ium spp. may induce cross-reactive responses with M.
bovis antigens [68]. The presence of PTB or other infec-
tions caused by environmental mycobacteria is an inter-
ference factor in the diagnosis of TB using PPDs [67],
but not using the ESAT-6/CFP-10 protein cocktail [68].
A limitation of this study was not including samples
from animals infected with other species of mycobac-
teria as control owing to limited BSL3 laboratory space
availability. Further studies are necessary to estimate the
effects of these other mycobacteria, in addition to the
single and comparative skin test, on IFNγ responses and
to evaluate the mechanisms involved in these effects.
We compared the potential of specific antigens,
present only in tuberculous mycobacteria and absent in
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non-tuberculous mycobacteria (ESAT-6/CFP-10,
Rv3615c and Rv3020c), for their use in this diagnostic test.
In particular, the use of these antigens may enhance the
Sp of IFNγ-based tests in comparison to that achieved
when standard PPDs are used as the eliciting agent.
The percentage of M. bovis-infected deer postitive to
the technique with individual M. bovis specific antigens
ranged widely depending on the antigens and the cut-off
value applied. Proteins encoded within the ESAT-6 gene
cluster (including ESAT-6 and CFP-10) of tuberculous
mycobacteria play an important role in the pathogenesis
of the disease, inducing potent T-cell responses that
have been used in TB diagnostic tests [28, 69, 70]. In the
present study, the peptides cocktail combining ESAT-6
and CFP-10 elicited robust recall IFNγ responses in M.
bovis-infected deer from 15 dpi onwards and reached a
satisfactory detection of infected animals (92.3 to 100%),
which is higher than in previous studies of domestic
ruminants [28, 36, 39, 53, 65]. However, the relatively
small sample size in our experiment resulted in a wide
95% CI, and future studies are required to confirm this
observation under field conditions. It is possible, for ex-
ample, that the high detection of M. bovis-infected ani-
mals seen in our study could be owing to the fact that
all the animals used were exposed to a high dose of M.
bovis and the samples were collected at an early stage of
the disease. This may have led us to observe a decrease
in the detection of TB-positive animals with all the anti-
gens at 60 dpi due to a possible anergy of the animals.
In contrast to the responses to ESAT-6/CFP-10, the
responses of M. bovis-infected deer to Rv3615c only
slightly exceeded the pre-infection values, with a max-
imum detection of TB-positive deer at 15 dpi when
40% of the animals elicited an IFNγ response to the
stimulation, similar to that which has been previously
reported for cattle [39]. Various authors have reported
that the use of Rv3615c in combination with ESAT-6
and CFP10 appears to increase the detection of TB-
positive deer without false positives in the IFNγ assay
[39, 56]. This observation is suggested by our results,
were the use of antigen combinations provided better
detection of infected animals. In particular, Rv3615c or
Rv3020c were found to recognize infected deer missed
by ESAT-6/CFP-10.
Conclusions
These findings indicate that the in-house sandwich
ELISA developed for red deer IFNγ and based on the
cross-reactivity with bovine IFNγ may serve as a valu-
able assay for the antemortem diagnosis of TB in deer
experimentally infected with M. bovis, as early as 15 dpi.
The suggested optimal antigens and cut-off are bPPD,
p22 and the combination of ESAT-6/CFP-10 and
Rv3020c with a 0.05 ΔOD. This yielded the detection of
up to 100% of the positive and negatve deer under our
experimental conditions. This technique will aid in TB
testing of farmed and translocated deer. It would be use-
ful to carry out further studies in order to evaluate the
ability of this IFNγ assay to detect specific responses in
field conditions.
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